Prostate Cancer
Optimizing biopsy decisions in PI-RADS 3 lesions: cross-institutional validation of a local clinical risk model.
April 29, 2025
Trends in Surgical Overtreatment of Prostate Cancer.
April 29, 2025
Optimizing therapy for high-risk biochemically recurrent non-metastatic prostate cancer: Current and emerging strategies.
April 28, 2025
Percentage of free to total PSA as a biomarker of survival in metastatic castration-resistant prostate cancer.
April 28, 2025
Sexual activity in men undergoing ADT for localized prostate cancer: a narrative literature review.
April 28, 2025
Acute BRCAness induction and AR pathway blockage through CDK12/7/9 degradation enhances PARP inhibitor sensitivity in prostate cancer.
April 25, 2025
Prostate-specific membrane antigen positron-emission tomography for novel risk-stratification of biochemical recurrence.
April 25, 2025
Evaluation of 3D ARFI imaging of prostate cancer: diagnostic reliability and concordance with MpMRI.
April 25, 2025